• Title/Summary/Keyword: Osteonecrosis

Search Result 181, Processing Time 0.032 seconds

The Clinical Study of Acupotomy and Oriental Medicine on Multiple Osteonecrosis of Femur and Tibia (대퇴골과 경골의 다발성 골괴사 환자에 대한 침도치료 및 한방치료 증례연구)

  • Sung, In-Su;Hong, Kwon-Eui
    • Journal of Acupuncture Research
    • /
    • v.28 no.5
    • /
    • pp.153-159
    • /
    • 2011
  • Objectives : Osteonecrosis is a disease where there is the cellular death of bone components due to interruption of the blood supply. In these days, the clinical study and research about osteonecrosis are increased, however the study on osteonecrosis in oriental medical way is hardly studied yet. Thus, we report the significant effect of acupotomy and oriental medicine on osteonecrosis which occurred in femur and tibia. Methods : We observed recovery of symptoms and decrease of osteonecrosis region in femur and tibia by MRI. Results : During five times of acupotomy, pain on right side thigh in rest time and knee joint pain during walk were decresed after 1st, 2nd, and 3rd acupotomy. In MRI, we observed decrease of osteonecrosis region in femur and tibia, that made the patient could return to daily life. Conclusions : Acupotomy and Oriental medicine have an significant effect on osteonecrosis by pain relief and osteonecrosis region decrease.

Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea

  • Hyeong-Jin Baek;Hyejin Lee;Jae-Ryun Lee;Jung-Hyun Park;Keun-Suh Kim;Min-Jeong Kwoen;Tae-Yeon Lee;Jin-Woo Kim;Hyo-Jung Lee
    • Journal of Periodontal and Implant Science
    • /
    • v.54 no.2
    • /
    • pp.65-74
    • /
    • 2024
  • Purpose: This longitudinal cohort study aimed to evaluate the relationship between osteonecrosis of the jaw and pulp and periapical disease in patients who were administered bisphosphonates. Methods: Using data from a nationwide cohort, we examined the association among dental caries, pulp and periapical disease, and osteonecrosis of the jaw in women aged >50 years who received bisphosphonates for more than 1 year between 2002 and 2015. Because of ambiguities in the diagnosis of osteonecrosis of the jaw in population-based data, we operationally defined and categorized the condition into established and potential osteonecrosis of the jaw. Results: Pulp and periapical disease significantly increased the development of both established and potential osteonecrosis of the jaw (hazard ratio, 2.21; 95% confidence interval, 1.40-3.48; and hazard ratio, 2.22; 95% confidence interval, 1.65-2.98, respectively). Root canal treatment did not have any influence on the development of osteonecrosis of the jaw. Conclusions: Pulp and periapical disease may be a major risk factor for osteonecrosis of the jaw. The study findings suggest that patients should undergo regular dental examinations to detect pulp and periapical disease before or during the administration of bisphosphonates and that root canal treatment should be considered to decrease the risk of osteonecrosis of the jaw.

Clinical feature and treatment of bisphosphonate-related osteonecrosis of jaw about oral bisphosphonate administrated patients: case reports (경구 bisphosphonate를 복용하는 환자에서 발생한 bisphosphonate-related osteonecrosis of jaw에 대한 임상적 특징 및 처치: 증례보고)

  • Choi, Woo-Sung;Yoon, Hyun-Joong;Lee, Sang-Hwa
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.36 no.6
    • /
    • pp.508-514
    • /
    • 2010
  • Bisphosphonates are used effectively for many medical conditions, such as multiple myeloma, Paget's disease, osteoporosis, etc. However, recently, osteonecrosis of the jaw was observed in patients receiving long-term bisphosphonate therapy, including oral administration. This osteonecrosis is refractory, and complete recovery is not guaranteed despite a standard treatment protocol being established by many associations related to oral and maxillofacial surgery. The treatment outcome of oral bisphosphonate-related osteonecrosis of jaw (BRONJ) is reported with a review of the relevant literature.

Bisphosphonate related osteonecrosis of jaw (비스포스포네이트(Bisphosphonate)를 복용하는 환자에서 발생하는 골괴사증)

  • Hwang, Kyung-Gyun
    • The Journal of the Korean dental association
    • /
    • v.49 no.7
    • /
    • pp.372-377
    • /
    • 2011
  • Bisphosphonates are widely used in the management of osteoporosis patients. Many reports and clinical studies have published a relationship between necrotic bone lesions localized to the jaw and the use of chronic bisphosphonate therapy. This osteonecrosis named bisphosphonate-related osteonecrosis of the jaw(BRONJ). This article described the mechanism, chemical structure, indication, risk factor of the bisphosphonate.

Mechanism, prevention, risk assessment and treatment in bisphosphonates induced osteonecrosis of the jaw (Bisphosphonates induced osteonecrosis of the jaw의 기전, 예방, 위험 평가 및 치료 방법)

  • Park, Jung-Chul;Jung, Ui-Won;Kim, Chang-Sung;Cho, Kyoo-Sung;Chai, Jung-Kiu;Kim, Chong-Kwan;Choi, Seong-Ho
    • Journal of Periodontal and Implant Science
    • /
    • v.39 no.1
    • /
    • pp.1-8
    • /
    • 2009
  • Purpose: Bisphosphonates are drugs used to suppress osteoclastic activity and to treat osteoporosis, Paget's disease of bone and bone metastasis. The purpose of this report is to review the literatures on bisphosphonates use that could affect bone healing and cause osteonecrosis of the jaws. Materials and methods: Medline research was carried out to find relevant articles on bisphosphonates and osteonecrosis of the jaw. Results: Oral administration of bisphosphonates is reported to decrease the risk of adverse bone outcomes. On the contrary, IV bisphosphonates is known to significantly increase the risk. Prevention of the osteonecrosis of the jaw is primary concern before usage. If the adverse bone reaction takes place, proper management and treatments are required to alleviate pain of patients and prevent further progression of necrosis. Conclusion: Case reports of bisphosphonates induced osteonecrosis of the jaw are increasing. Dentists and physicians should be aware of the higher frequency of osteonecrosis of the jaw in patients receiving IV bisphosphonates and be prepared to prevent and cope with adverse bone reaction.

Rapidly Progressive Osteonecrosis of the Humeral Head after Arthroscopic Bankart and Rotator Cuff Repair in a 66-Year Old Woman: A Case Report

  • Cho, Hyun IK;Cho, Hyung Lae;Hwang, Tae Hyok;Wang, Tae Hyun;Cho, Hong
    • Clinics in Shoulder and Elbow
    • /
    • v.18 no.3
    • /
    • pp.167-171
    • /
    • 2015
  • Humeral head chondrolysis has been widely reported as a devastating complication after arthroscopic shoulder surgery; however little is known about post-arthroscopic humeral head osteonecrosis. We experienced a 66-year-old female patient with rapidly progressive osteonecrosis of the humeral head only seven months after arthroscopic Bankart and rotator cuff repair. The patient had no systemic risk factors for osteonecrosis. A satisfactory result was achieved with reverse total shoulder arthroplasty for severe humeral head destruction and an irreparable massive rotator cuff tear. Shoulder surgeons should be aware of such severe complication, perform routine radiographs, and pay close attention to the presence of constant pain or loss of motion after arthroscopic shoulder surgery.

A Case Report of Sequela of Operation of Talus Osteonecrosis (Osteonecrosis 수술 후 족과부동통(足踝部疼痛) 후유증 치험 1례)

  • Choi, Sung-Hun;Kim, Kyung-Un;Lee, Yoon-Kyoung;Lee, Kyung-Min;Lim, Seong-Chul;Jung, Tae-Young;Seo, Jung-Chul
    • Journal of Pharmacopuncture
    • /
    • v.9 no.1
    • /
    • pp.115-120
    • /
    • 2006
  • Objective : The clinic study or report about Oriental Medical treatment about osteonecrosis is very insufficient. Therefore, we report a case about a sequela of operation of talus osteonecrosis treated by Oriental Medical treatments. Methods : The patient was managed by bee venom and Carthami Flos Herbal-Acupuncture, Sa-am and body acupucture, moxibustion, physical theraphy and herbal medicine. We evaluated the patient through Visual Analogue Scale(VAS). Results : After 25 days of treatment, the patient showed that clinical symptoms was decreased and VAS changed from 10 to 2. Conclusion : In this case, Oriental Medical treatments for a sequela of operation of talus osteonecrosis was effective. But further studies are required to confirm the effect of these methods.

CLINICAL STUDY OF BISPHOSPHONATE-INDUCED OSTEONECROSIS OF MANDIBULAR AND MAXILLARY BONE (비스포스포네이트로 인한 하악 및 상악골에 발생한 골괴사에 대한 임상적 연구)

  • Joeng, Hye-Rin;Kim, Tae-Wan;Lee, Jeong-Keun;Song, Seung-Il
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.35 no.5
    • /
    • pp.353-360
    • /
    • 2009
  • Bisphosphonates are compounds widely used in the treatment of various metabolic and malignant bone disease. Recently, an association between bisphosphonate use and a rare dental condition termed 'osteonecrosis of the jaw(ONJ)' has been reported. Bisphosphonate-related osteonecrosis of the jaw(BRONJ) is rare, but serious, side effect of bisphosphonate therapy in affected patients. It is characterized by poor wound healing and spontaneous intra-oral soft tissue break down, which lead to exposure of necrotic maxillary and mandibular bone. We reviewed 11 patients of BRONJ visited Ajou University Hospital Dental clinic from May 2007 to November 2008. The management of the patients included cessation of bisphosphonate therapy and various surgical restorative procedures and conservative care there after. Aggressive debridement is contraindicated. A new complication of bisphosphonate therapy administration, osteonecrosis of jaws, seems to be developing. The improved results after cessation of the medication should make clinicians reconsider the merits of the rampant use of bisphosphonates, while further investigation is needed to completely elucidate this complication.

Familial Osteonecrosis of Femoral Condyle -Atypical Spontaneous Osteonecrosis of the Knee Involving Medial & Lateral Condyles in Young Patient with Familial Occurence- (비전형적 대퇴골과 자발성 골괴사증(증례 보고))

  • Lee, Myung Chul;Jo, Hyun Chul;Kim, Tae Gyun;Seong, In Ho;Seong, Sang Cheol
    • Journal of the Korean Arthroscopy Society
    • /
    • v.2 no.2
    • /
    • pp.185-188
    • /
    • 1998
  • Spontaneous osteonecrosis of the knee was first described by Ahlbck et al in 1968 as the spontaneous and sudden onset of severe pain, usually on the medial side of the knee joint, in old age(>60 years) with no specific etiologic factors. They differentiate the disease from osteochondritis dissecans, osteoarthritis, fracture, infection, neuropathic joint and secondary osteonecrosis of the knee joint. So far many investigators described this disease but had never observed cases developed in young patient with familial occurrence. The report presented here is a case of spontaneous osteonecrosis of both medial and lateral femoral condyles involving the bilateral knee joint that were treated by arthorscopic loose body removal and multiple drilling.

  • PDF

Biochemical bone markers of bisphosphonate-related osteonecrosis of the jaw (BRONJ) and nonbisphosphonate drugs in osteonecrosis of the jaw (임상가를 위한 특집 2 - Bisphosphonate-related osteonecrosis of the jaw(BRONJ)에 대한 biochemical bone markers와 악골괴사와 연관된 nonbisphosphonate drugs)

  • Lee, Deok-Won;Lee, Hyun-Woo;Kwon, Yong-Dae
    • The Journal of the Korean dental association
    • /
    • v.52 no.4
    • /
    • pp.203-217
    • /
    • 2014
  • Bisphosphonates are widely used in the treatment of many medical conditions, such as osteoporosis, multiple myeloma, Paget's disease, etc. However, side effect has been documented in the published data during the past years, osteonecrosis of the jaw in patients receiving long-term bisphosphonate therapy. Although pathogenesis of BRONJ(bisphophonate-related osteonecrosis of the jaw) is not yet fully understood, it is currently known to be a disease associated with suppressed bone turnover by bisphopbonate. Recent literature has indicated a similar association with nonbisphosphonate drugs used in cancer therapy including monoclonal antibodies denosumab and bevacizumab and multikinase inhibitor sunitinib. Accordingly, many studies have been carried out on the biochemical markers examination to assess the risk for BRONJ. The treatment of BRONI is reported with a review of the relevant literature. However, there is still a controversial discussion about the adequate treatment. It is necessary to accumulate further studies in order to establish more useful biochemical markers and effective treatment for BRONJ.